| Product NDC: | 60432-093 |
| Proprietary Name: | Amantadine Hydrochloride |
| Non Proprietary Name: | AMANTADINE HYDROCHLORIDE |
| Active Ingredient(s): | 50 mg/5mL & nbsp; AMANTADINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60432-093 |
| Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075060 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19981224 |
| Package NDC: | 60432-093-16 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (60432-093-16) |
| NDC Code | 60432-093-16 |
| Proprietary Name | Amantadine Hydrochloride |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (60432-093-16) |
| Product NDC | 60432-093 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | AMANTADINE HYDROCHLORIDE |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 19981224 |
| Marketing Category Name | ANDA |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | AMANTADINE HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |